Association of the risk for Thrombotic Thrombocytopenia Syndrome and Exposure To COVID-19 vaccines - ATTEST

Study identifier:D8111R00010

ClinicalTrials.gov identifier:NCT05252442

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

An Assessment of a relationship between the exposure to COVID-19 vaccines and risk of thrombotic thrombocytopenia syndrome ATTEST study (Association of the risk for Thrombotic Thrombocytopenia Syndrome and Exposure To COVID-19 vaccines)

Medical condition

COVID-19

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

7641136

Study type

Observational

Age

16 Years - n/a

Date

Study Start Date: 01 Mar 2022
Primary Completion Date: 11 Jul 2023
Study Completion Date: 11 Jul 2023

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 May 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria